Global Clinical Trial Supply Services Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Clinical Trial Supply Services Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Clinical Trial Supply Services refers to the manufacturing, packaging, storage, distribution, project management, and inventory management for in clinical trial activities. Clinical Trial Supply Services include, but are not limited to, project management, clinical packaging, labeling, supply chain logistics, distribution, return drug accountability, and destruction.

Market Overview:

The latest research study on the global Clinical Trial Supply Services market finds that the global Clinical Trial Supply Services market reached a value of USD 3550.62 million in 2022. It’s expected that the market will achieve USD 5340.48 million by 2028, exhibiting a CAGR of 7.04% during the forecast period.

The number of new groups in clinical trials dropped sharply at the beginning of the year because of COVID-19

Globally, COVID-19 is still raging. Many pharmaceutical companies suspend clinical trials due to the epidemic. Because of the recruitment of patients in most regions of the world was severely affected. In March, the number of enrolled groups in global clinical trials dropped by 65.1% year-on-year compared with 2019

European Medicines Agency (EMA), U.S. Food and Drug Administration (FDA), British Medicines and Healthcare Products Administration (MHRA), British National Health Service (NHS) and British Department of Health and Social Care (DHSC), Japanese Medicines And the Medical Device Administration (PMDA), Health Canada, Singapore's Health Sciences Agency (HSA), the American Association of Clinical Research Organizations (ACRO) and multiple ethical review committees have issued updated emergency response measures for clinical trials guidance during the COVID-19. In China alone, the number of newly enrolled patients participating in clinical trials in March decreased by 68% compared with the same period last year, so the demand for production and logistics services will also decline. But the good news is that after March, the number of newly enrolled patients began to rise sharply, and the number of new patients increased by 240% in March compared with February. This is a positive sign that clinical trials are gradually picking up.

Rising demand for outsourcing of drug discovery services

The global clinical trial market is thriving on account of the rising impetus given to research and development across several industries. Drug discovery forms an important niche of the pharmaceutical industry, and the extensive efforts employed by researchers to invent new drug models have popularized the market. Pharmaceutical companies have become increasingly concerned about manufacturing novel drugs and freeing the process of drug discovery from any hassles. Hence, outsourcing of drug discovery has emerged as a prominent trend amongst these companies, which has propelled demand within the market. Such as the prevalence of chronic diseases such as various cancer types and the increasing popularity of drug discovery service outsourcing will effectively promote the manufacturing demand in clinical trial supply services.

Strict and changing regulatory environment

Since clinical trial supply services are closely related to life and health, many regions have strict supervision systems for the production and packaging of clinical trials. The FDA and other regulatory agencies have increased stringency on the quality, storage, packaging and labeling, distribution, and recall of auxiliary products. The company now purchases auxiliary products at different levels, such as central procurement and regional procurement.

In addition, over a period of time, the regulatory environment in many countries/regions is very dynamic and changes rapidly. The constant changes in regulations and regional regulatory agencies will affect the import of clinical trial supplies. Using import brokers to overcome regional difficulties, such as complying with import and export regulations for the transportation of clinical trial supplies, will affect pharmaceutical companies in the smooth progress of clinical trials.

Region Overview:

Geographically, North America held the largest market share – 42.78% in 2021.

Company Overview:

Thermo Fisher Scientific is one of the major players operating in the Clinical Trial Supply Services market, holding a share of 16.27% in 2021.

Thermo Fisher Scientific

Thermo Fisher Scientific, Inc. manufactures scientific instruments, consumables, and chemicals. The Company offers analytical instruments, laboratory equipment, software, services, consumables, reagents, chemicals, and supplies to pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions, and government agencies.

Catalent Pharma Solutions

Catalent, Inc. provides delivery technologies and development solutions for drugs, biologics, and consumer health products. The Company's oral, injectable, and respiratory delivery technologies address the diversity of the pharmaceutical industry including small molecules, large molecule biologics, and consumer health products.

Segmentation Overview:

By type, Logistics and Distribution segment accounted for the largest share of market in 2021.

Application Overview:

The market's largest segment by application is the segment Oncology, with a market share of 20.97% in 2021.

Key Companies in the global Clinical Trial Supply Services market covered in Chapter 3:

World Courier
Thermo Fisher Scientific
Biocair
Movianto
PCI Services
Clinigen
Piramal Pharma Solutions
Almac Group
MARKEN (UPS)
Sharp (UDG Healthcare)
Catalent Pharma Solutions
Bilcare Limited
Parexel International

In Chapter 4 and Chapter 14.2, on the basis of types, the Clinical Trial Supply Services market from 2018 to 2029 is primarily split into:

Logistics and Distribution
Packaging and Labeling
Manufacturing
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Clinical Trial Supply Services market from 2018 to 2029 covers:

Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS and Mental Disorders
Dermatology
Blood Disorders
Infectious Diseases
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)